These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 14532270)

  • 21. Pael receptor is involved in dopamine metabolism in the nigrostriatal system.
    Imai Y; Inoue H; Kataoka A; Hua-Qin W; Masuda M; Ikeda T; Tsukita K; Soda M; Kodama T; Fuwa T; Honda Y; Kaneko S; Matsumoto S; Wakamatsu K; Ito S; Miura M; Aosaki T; Itohara S; Takahashi R
    Neurosci Res; 2007 Dec; 59(4):413-25. PubMed ID: 17889953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppressive effects of 4-phenylbutyrate on the aggregation of Pael receptors and endoplasmic reticulum stress.
    Kubota K; Niinuma Y; Kaneko M; Okuma Y; Sugai M; Omura T; Uesugi M; Uehara T; Hosoi T; Nomura Y
    J Neurochem; 2006 Jun; 97(5):1259-68. PubMed ID: 16539653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Parkin, alpha-synuclein and other molecular aspects of Parkinson's disease].
    Corti O; Brice A
    J Soc Biol; 2002; 196(1):95-10. PubMed ID: 12134640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parkin Co-Regulated Gene (PACRG) is regulated by the ubiquitin-proteasomal system and is present in the pathological features of Parkinsonian diseases.
    Taylor JM; Song YJ; Huang Y; Farrer MJ; Delatycki MB; Halliday GM; Lockhart PJ
    Neurobiol Dis; 2007 Aug; 27(2):238-47. PubMed ID: 17590346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Autosomal recessive juvenile parkinsonism: its pathogenesis is involved in the ubiquitin-proteasome pathway].
    Hattori N; Shimura H; Kubo S; Suzuki T; Tanaka K; Mizuno Y
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1293-6. PubMed ID: 11464483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation.
    Lim KL; Chew KC; Tan JM; Wang C; Chung KK; Zhang Y; Tanaka Y; Smith W; Engelender S; Ross CA; Dawson VL; Dawson TM
    J Neurosci; 2005 Feb; 25(8):2002-9. PubMed ID: 15728840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parkin attenuates manganese-induced dopaminergic cell death.
    Higashi Y; Asanuma M; Miyazaki I; Hattori N; Mizuno Y; Ogawa N
    J Neurochem; 2004 Jun; 89(6):1490-7. PubMed ID: 15189352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Siah-1 facilitates ubiquitination and degradation of synphilin-1.
    Nagano Y; Yamashita H; Takahashi T; Kishida S; Nakamura T; Iseki E; Hattori N; Mizuno Y; Kikuchi A; Matsumoto M
    J Biol Chem; 2003 Dec; 278(51):51504-14. PubMed ID: 14506261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin.
    Imai Y; Soda M; Inoue H; Hattori N; Mizuno Y; Takahashi R
    Cell; 2001 Jun; 105(7):891-902. PubMed ID: 11439185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of Pael-R expression in a Parkinson's disease cell model reduces apoptosis.
    Zou T; Xiao B; Tang J; Zhang H; Tang X
    J Clin Neurosci; 2012 Oct; 19(10):1433-6. PubMed ID: 22898202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of the parkin gene and protein in understanding Parkinson's disease.
    Fishman PS; Oyler GA
    Curr Neurol Neurosci Rep; 2002 Jul; 2(4):296-302. PubMed ID: 12044248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease.
    Liani E; Eyal A; Avraham E; Shemer R; Szargel R; Berg D; Bornemann A; Riess O; Ross CA; Rott R; Engelender S
    Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5500-5. PubMed ID: 15064394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parkin is metabolized by the ubiquitin/proteosome system.
    Choi P; Ostrerova-Golts N; Sparkman D; Cochran E; Lee JM; Wolozin B
    Neuroreport; 2000 Aug; 11(12):2635-8. PubMed ID: 10976934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pathogenesis of Parkinson's disease: a common pathway between alpha-synuclein and parkin and the mechanism of Lewy bodies formation].
    Hattori N; Machida Y; Noda K
    Rinsho Shinkeigaku; 2005 Nov; 45(11):905-7. PubMed ID: 16447759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell type-specific upregulation of Parkin in response to ER stress.
    Wang HQ; Imai Y; Kataoka A; Takahashi R
    Antioxid Redox Signal; 2007 May; 9(5):533-42. PubMed ID: 17465879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted overexpression of the parkin substrate Pael-R in the nigrostriatal system of adult rats to model Parkinson's disease.
    Dusonchet J; Bensadoun JC; Schneider BL; Aebischer P
    Neurobiol Dis; 2009 Jul; 35(1):32-41. PubMed ID: 19348945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The C289G and C418R missense mutations cause rapid sequestration of human Parkin into insoluble aggregates.
    Gu WJ; Corti O; Araujo F; Hampe C; Jacquier S; Lücking CB; Abbas N; Duyckaerts C; Rooney T; Pradier L; Ruberg M; Brice A
    Neurobiol Dis; 2003 Dec; 14(3):357-64. PubMed ID: 14678753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Animal models for familial Parkinson's disease].
    Takahashi R
    Rinsho Shinkeigaku; 2007 Nov; 47(11):938-40. PubMed ID: 18210841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parkin co-regulated gene is involved in aggresome formation and autophagy in response to proteasomal impairment.
    Taylor JM; Brody KM; Lockhart PJ
    Exp Cell Res; 2012 Oct; 318(16):2059-70. PubMed ID: 22652456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical localization of a ubiquitin ligase HRD1 in murine brain.
    Omura T; Kaneko M; Tabei N; Okuma Y; Nomura Y
    J Neurosci Res; 2008 May; 86(7):1577-87. PubMed ID: 18241051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.